FR2821855B1
(fr)
†
|
2001-03-09 |
2004-04-02 |
Cayla |
Genes synthetiques et plasmides bacteriens depourvus de cpg
|
WO2002099105A2
(en)
*
|
2001-06-05 |
2002-12-12 |
Cellectis |
Methods for modifying the cpg content of polynucleotides
|
DK1572994T3
(da)
|
2002-12-20 |
2007-05-29 |
Chromagenics Bv |
Midler og fremgangsmåder til fremstilling af en protein gennem chromatinåbnere, som kan göre chromatin mere tilgængeligt for transkriptionsfaktorer
|
US20100136616A1
(en)
*
|
2004-11-08 |
2010-06-03 |
Chromagenics B.V. |
Selection of Host Cells Expressing Protein at High Levels
|
US8039230B2
(en)
*
|
2004-11-08 |
2011-10-18 |
Chromagenics B.V. |
Selection of host cells expressing protein at high levels
|
JP5291341B2
(ja)
*
|
2004-11-08 |
2013-09-18 |
クロマジェニックス ベー ヴェー |
タンパク質を高レベルで発現する宿主細胞の選定
|
ES2384391T3
(es)
*
|
2004-11-08 |
2012-07-04 |
Chromagenics B.V. |
Selección de células hospedantes que expresan proteína a altos niveles
|
US20060195935A1
(en)
|
2004-11-08 |
2006-08-31 |
Chromagenics B.V. |
Selection of host cells expressing protein at high levels
|
US8999667B2
(en)
|
2004-11-08 |
2015-04-07 |
Chromagenics B.V. |
Selection of host cells expressing protein at high levels
|
GB0606190D0
(en)
|
2006-03-28 |
2006-05-10 |
Isis Innovation |
Construct
|
WO2009149470A1
(en)
*
|
2008-06-06 |
2009-12-10 |
Aurora Biofuels, Inc. |
Vcp-based vectors for algal cell transformation
|
US20100022393A1
(en)
*
|
2008-07-24 |
2010-01-28 |
Bertrand Vick |
Glyphosate applications in aquaculture
|
US8314228B2
(en)
|
2009-02-13 |
2012-11-20 |
Aurora Algae, Inc. |
Bidirectional promoters in Nannochloropsis
|
US8865468B2
(en)
*
|
2009-10-19 |
2014-10-21 |
Aurora Algae, Inc. |
Homologous recombination in an algal nuclear genome
|
US8809046B2
(en)
|
2011-04-28 |
2014-08-19 |
Aurora Algae, Inc. |
Algal elongases
|
WO2011011463A2
(en)
*
|
2009-07-20 |
2011-01-27 |
Aurora Biofuels, Inc. |
Manipulation of an alternative respiratory pathway in photo-autotrophs
|
US20120213848A1
(en)
*
|
2010-11-16 |
2012-08-23 |
Hanley Brian P |
Treatment of Infection Using Single Chain Antibody Gene Therapy
|
US8722359B2
(en)
|
2011-01-21 |
2014-05-13 |
Aurora Algae, Inc. |
Genes for enhanced lipid metabolism for accumulation of lipids
|
CN103974966A
(zh)
|
2011-04-28 |
2014-08-06 |
奥罗拉藻类股份有限公司 |
藻类去饱和酶
|
US8435777B1
(en)
|
2012-01-20 |
2013-05-07 |
Cayla |
CPG-free gene for a new secreted reporter protein
|
WO2013166065A1
(en)
|
2012-04-30 |
2013-11-07 |
Aurora Algae, Inc. |
ACP Promoter
|
US10612034B2
(en)
*
|
2012-06-01 |
2020-04-07 |
Exxonmobil Research And Engineering Company |
Promoters and terminators for use in eukaryotic cells
|
AU2013309488A1
(en)
|
2012-08-29 |
2015-03-05 |
Nature Technology Corporation |
DNA plasmids with improved expression
|
WO2014077863A1
(en)
|
2012-11-19 |
2014-05-22 |
Nature Technology Corporation |
Replicative minicircle vectors with improved expression
|
US11124845B2
(en)
*
|
2014-03-18 |
2021-09-21 |
The Johns Hopkins University |
PSMA-based molecular-genetic reporter system
|
JP6815986B2
(ja)
|
2014-03-26 |
2021-01-20 |
ユニバーシティ オブ メリーランド, カレッジ パーク |
大型家畜の接合体における標的化ゲノム編集
|
JP7014721B2
(ja)
|
2015-09-18 |
2022-02-01 |
ディーエヌエーアールエックス |
インビボでの核酸発現のためのシステム及び方法
|
EP3600428A4
(en)
|
2017-03-23 |
2020-08-26 |
Dnarx |
SYSTEMS AND METHODS FOR THE EXPRESSION OF NUCLEIC ACIDS IN VIVO
|
GB201714330D0
(en)
|
2017-09-06 |
2017-10-18 |
Järver Peter |
Oligonucleotides
|
WO2019057774A1
(en)
|
2017-09-19 |
2019-03-28 |
Deutsches Krebsforschungszentrum |
NON-INTEGRATING DNA VECTORS FOR THE GENETIC MODIFICATION OF CELLS
|
ES2821655T5
(es)
|
2017-09-19 |
2024-08-06 |
Deutsches Krebsforsch |
Vectores de ADN no integrantes para la modificación genética de células
|
LT3768846T
(lt)
|
2018-03-21 |
2023-08-10 |
Aldevron, L.L.C. |
Virusiniai ir nevirusiniai nanoplazmidiniai vektoriai su patobulinta gamyba
|
CN112359006B
(zh)
*
|
2019-07-05 |
2022-07-22 |
苏州华赛生物工程技术有限公司 |
生产胞嘧啶的重组微生物及生产胞嘧啶的方法
|
WO2021055760A1
(en)
|
2019-09-18 |
2021-03-25 |
Intergalactic Therapeutics, Inc. |
Synthetic dna vectors and methods of use
|
FR3111913A1
(fr)
|
2020-06-30 |
2021-12-31 |
Eyevensys |
Construction d’adn pour le traitement de pathologies oculaires
|